These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 7798424

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Disordered cyclic nucleotide metabolism--a basic defect in atopic dermatitis.
    Butler JM.
    Australas J Dermatol; 1984 Apr; 25(1):3-7. PubMed ID: 6205650
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pathophysiologic mechanisms in atopic dermatitis.
    Boguniewicz M, Leung DY.
    Semin Cutan Med Surg; 2001 Dec; 20(4):217-25. PubMed ID: 11770908
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Modulation of leukocyte cyclic AMP phosphodiesterase activity by recombinant interferon-gamma: evidence for a differential effect on atopic monocytes.
    Li SH, Chan SC, Kramer SM, Hanifin JM.
    J Interferon Res; 1993 Jun; 13(3):197-202. PubMed ID: 8396165
    [Abstract] [Full Text] [Related]

  • 7. Response of mononuclear leukocyte cyclic adenosine monophosphate-phosphodiesterase activity to treatment with topical fluorinated steroid ointment in atopic dermatitis.
    Holden CA, Yuen CT.
    J Am Acad Dermatol; 1989 Jul; 21(1):69-74. PubMed ID: 2545750
    [Abstract] [Full Text] [Related]

  • 8. Cyclic adenosine monophosphate-phosphodiesterase activity in cultured keratinocytes from patients with atopic eczema.
    Wright S, Navsaria H, Leigh IM.
    J Dermatol Sci; 1991 Jul; 2(4):263-7. PubMed ID: 1655006
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Differential inhibitor effects on cyclic adenosine monophosphate-phosphodiesterase isoforms in atopic and normal leukocytes.
    Chan SC, Hanifin JM.
    J Lab Clin Med; 1993 Jan; 121(1):44-51. PubMed ID: 8381148
    [Abstract] [Full Text] [Related]

  • 15. Elevated leukocyte cyclic AMP-phosphodiesterase in atopic disease: a possible mechanism for cyclic AMP-agonist hyporesponsiveness.
    Grewe SR, Chan SC, Hanifin JM.
    J Allergy Clin Immunol; 1982 Dec; 70(6):452-7. PubMed ID: 6128357
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Advances in nondietary management of children with atopic dermatitis.
    Rasmussen JE.
    Pediatr Dermatol; 1989 Sep; 6(3):210-5. PubMed ID: 2552424
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Therapeutic benefit of PDE4 inhibitors in inflammatory diseases.
    Dastidar SG, Rajagopal D, Ray A.
    Curr Opin Investig Drugs; 2007 May; 8(5):364-72. PubMed ID: 17520865
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.